Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer

Medical Oncology

Volumn 22, Issue 2, 2005, Pages 123-128

  Kosmas, Christos ^a,c   Tsavaris, Nicolas B ^b   Soukouli, Georgia ^a   Gouveris, Panagiotis ^b   Tsakonas, George ^a   Katselis, John ^a   Alexopoulos, Heraklis ^a   Mylonakis, Nicolas ^a   Karabelis, Athanasios ^a  

^a METAXA CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NONE   (Greece)

Author keywords

Breast cancer; Carcinomatous meningitis; Tumor markers

Indexed keywords

CYTARABINE; METHOTREXATE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; EVALUATION; HUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; TREATMENT OUTCOME;

AGED; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DISEASE PROGRESSION; FEMALE; HUMANS; MENINGEAL NEOPLASMS; MENINGITIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 22344454352     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:22:2:123     Document Type: Article

References (8)

1. Posner JB. Neurologic Complications of Cancer. F.A. Davis: Philadelphia, PA, 1995, pp. 143-168.
2. Clayton AJ, et al. Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer 2004; 91: 639-643.
3. Yap BS, Yap HY, Fritsche HA, Blumenschein G, Bodey GP. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer. JAMA 1980; 244: 1601-1603.
4. Glantz MJ, et al. Cerebrospinal fluid cytology in patients with cancer, minimizing false-negative results. Cancer 1998; 82: 733-739.
5. Glantz MJ, et al. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 1999; 5: 3394-3402.
6. Bagshawe KD, Harland SJ. Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system. Cancer 1976; 38: 112-118.
7. van Oostenbrugge RJ, Hopman AHN, Arends JW, Ramaekers FCS, Twijnstra A. Treatment of leptomeningeal metastases evaluated by interface cytogenetics. J Clin Oncol 2000; 18: 2053-2058.
8. Stockhammer G, et al. Vascular endothelial growth factor in CSF. A biological marker for carcinomatous meningitis. Neurology 2000; 54: 1670-1675.